ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
Innovative therapies to tackle platinum-resistant ovarian cancer
Nature
◽
10.1038/d41586-021-03718-6
◽
2021
◽
Vol 600
(7889)
◽
pp. S45-S47
Author(s):
Amanda B. Keener
Keyword(s):
Ovarian Cancer
◽
Platinum Resistant
◽
Innovative Therapies
Download Full-text
Related Documents
Cited By
References
A molecular signature for identification of platinum resistant ovarian cancer
Geburtshilfe und Frauenheilkunde
◽
10.1055/s-0028-1088857
◽
2008
◽
Vol 68
(S 01)
◽
Author(s):
T Fehm
◽
M Bonin
◽
J Hoffmann
◽
K Sotlar
◽
E Solomayer
◽
...
Keyword(s):
Ovarian Cancer
◽
Molecular Signature
◽
Platinum Resistant
Download Full-text
Temsirolimus in women with platinum-resistant ovarian cancer or advanced/recurrent endometrial cancer: a multicenter phase II trial of the AGO Study Group (AGO-GYN 8)
Geburtshilfe und Frauenheilkunde
◽
10.1055/s-0034-1388557
◽
2014
◽
Vol 74
(S 01)
◽
Author(s):
F Hilpert
◽
C Kurzeder
◽
B Schmalfeldt
◽
P Neuser
◽
N de Gregorio
◽
...
Keyword(s):
Ovarian Cancer
◽
Endometrial Cancer
◽
Phase Ii
◽
Phase Ii Trial
◽
Study Group
◽
Multicenter Phase
◽
Platinum Resistant
◽
Recurrent Endometrial Cancer
Download Full-text
The PACOVAR-trial: A multicenter phase I trial of pazopanib (GW786034) and metronomic cyclophosphamide in patients with recurrent platinum-resistant ovarian cancer
Geburtshilfe und Frauenheilkunde
◽
10.1055/s-0036-1592664
◽
2016
◽
Vol 76
(10)
◽
Author(s):
C Mayer
◽
M Schmidt
◽
EM Grischke
◽
G Gebauer
◽
HC Fricke
◽
...
Keyword(s):
Ovarian Cancer
◽
Phase I
◽
Phase I Trial
◽
Multicenter Phase
◽
Platinum Resistant
◽
Metronomic Cyclophosphamide
Download Full-text
COMPARISON OF GENE MUTATIONAL ANALYSES, INCLUDING BRCA1 ALTERATIONS, IN TWO PROSPECTIVE STUDIES IN NEWLY DIAGNOSED VERSUS PLATINUM-RESISTANT OVARIAN CANCER
10.26226/morressier.599bdc7ad462b80296ca1917
◽
2017
◽
Author(s):
Regula Deurloo
Keyword(s):
Ovarian Cancer
◽
Prospective Studies
◽
Newly Diagnosed
◽
Platinum Resistant
Download Full-text
Cancer Stem Cell Assay Directed Chemotherapy in Recurrent Platinum Resistant Ovarian Cancer
Case Medical Research
◽
10.31525/ct1-nct03949283
◽
2019
◽
Author(s):
Keyword(s):
Ovarian Cancer
◽
Stem Cell
◽
Cancer Stem Cell
◽
Cell Assay
◽
Platinum Resistant
Download Full-text
Efficacy and Safety of Niraparib Combined With Oral Etoposide in Platinum Resistant/Refractory Recurrent Ovarian Cancer
Case Medical Research
◽
10.31525/ct1-nct04217798
◽
2020
◽
Author(s):
Keyword(s):
Ovarian Cancer
◽
Recurrent Ovarian Cancer
◽
Oral Etoposide
◽
Efficacy And Safety
◽
Resistant Refractory
◽
Platinum Resistant
Download Full-text
Faculty Opinions recommendation of PRECEDENT: a randomized phase II trial comparing vintafolide (EC145) and pegylated liposomal doxorubicin (PLD) in combination versus PLD alone in patients with platinum-resistant ovarian cancer.
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
◽
10.3410/f.718144304.793486590
◽
2013
◽
Author(s):
Roberto Angioli
Keyword(s):
Ovarian Cancer
◽
Phase Ii
◽
Liposomal Doxorubicin
◽
Phase Ii Trial
◽
Pegylated Liposomal Doxorubicin
◽
Platinum Resistant
◽
Randomized Phase Ii
Download Full-text
Faculty Opinions recommendation of Randomized multicenter phase II trial comparing two schedules of etirinotecan pegol (NKTR-102) in women with recurrent platinum-resistant/refractory epithelial ovarian cancer.
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
◽
10.3410/f.718128610.793486222
◽
2013
◽
Author(s):
David Kushner
◽
Erin Medlin
Keyword(s):
Ovarian Cancer
◽
Epithelial Ovarian Cancer
◽
Phase Ii
◽
Phase Ii Trial
◽
Resistant Refractory
◽
Multicenter Phase
◽
Platinum Resistant
◽
Etirinotecan Pegol
Download Full-text
The role of surgery in platinum-resistant ovarian cancer: A call to the scientific community
Seminars in Cancer Biology
◽
10.1016/j.semcancer.2021.02.009
◽
2021
◽
Author(s):
Marco Petrillo
◽
Giulio Sozzi
◽
Margherita Dessole
◽
Giampiero Capobianco
◽
Salvatore Dessole
◽
...
Keyword(s):
Ovarian Cancer
◽
Scientific Community
◽
Platinum Resistant
Download Full-text
Predicting response to platinum and non-platinum drugs through bioluminescence resonance energy transfer (BRET) based bio-molecular interactions in platinum resistant epithelial ovarian cancer
Translational Oncology
◽
10.1016/j.tranon.2021.101193
◽
2021
◽
Vol 14
(11)
◽
pp. 101193
Author(s):
Aniketh Bishnu
◽
Megha Mehrotra
◽
Ajit Dhadve
◽
Shalini Dimri
◽
Abhijit De
◽
...
Keyword(s):
Ovarian Cancer
◽
Energy Transfer
◽
Epithelial Ovarian Cancer
◽
Molecular Interactions
◽
Resonance Energy Transfer
◽
Resonance Energy
◽
Platinum Drugs
◽
Bioluminescence Resonance Energy Transfer
◽
Platinum Resistant
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close